Cancer Moonshot℠ – Funding Opportunities

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The funding opportunity announcements (FOAs) listed below highlight research initiatives that align with the efforts of the Cancer Moonshot. They may be supported with existing funds or with the 21st Century Cures funding.

Planning for implementation of longer-term scientific initiatives is also underway. We will continue to update this page as new funding opportunities become available so check back often or sign up to receive automatic email updates on Cancer Moonshot-related activities.

Learn about the upcoming funding opportunities presented at the joint meeting of the National Cancer Advisory Board and the Board of Scientific Advisors.

Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.

Open Funding Opportunity Announcements (FOA)
BRP Recommendation Title Announcement Number Opening Date Expiration Date
Cancer Immunotherapy Translational Science Network Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) PAR-17-244 1/5/2016 5/8/2020
Cancer Immunotherapy Translational Science Network Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) PAR-17-245 1/5/2016 5/8/2020
Cancer Immunotherapy Translational Science Network Metabolic Reprogramming to Improve Immunotherapy (R01) PAR-16-228 9/5/2016 9/8/2019
Cancer Immunotherapy Translational Science Network Metabolic Reprogramming to Improve Immunotherapy (R21) PAR-16-229 9/16/2016 9/8/2019
Fusion Oncoproteins in Childhood Cancers Gene Fusions in Pediatric Sarcomas (R01) PA-16-251 9/5/2016 5/8/2019
Fusion Oncoproteins in Childhood Cancers Gene Fusions in Pediatric Sarcomas (R21) PA-16-252 9/16/2016 5/8/2019
Fusion Oncoproteins in Childhood Cancers Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp) PA-17-138 3/1/2017 3/29/2018
Fusion Oncoproteins in Childhood Cancers Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54) RFA-CA-17-049 10/15/2017 11/16/2017
Prevention and Early Detection: Implementation Science Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21) PAR-16-201 9/11/2016 6/14/2019
Prevention and Early Detection: Implementation Science Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01) PAR-16-202 9/11/2016 6/14/2019
Prevention and Early Detection: Implementation Science Dissemination and Implementation Research in Health (R21) PAR-16-236 5/16/2016 5/8/2019
Prevention and Early Detection: Implementation Science Dissemination and Implementation Research in Health (R01) PAR-16-238 5/10/2016 5/8/2019
Prevention and Early Detection: Implementation Science Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) RFA-CA-17-041 12/9/2017 1/10/2018
Generation of Human Tumor Atlases Emerging Questions in Cancer Systems Biology (U01) PAR-16-131 5/24/2016 11/24/2018
New Enabling Technologies Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp) PA-17-143 3/12/2017 12/13/2017
Closed Funding Opportunity Announcements (FOA)
BRP Recommendation Title Announcement Number Opening Date Expiration Date
Cancer Immunotherapy Translational Science Network Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp) PA-17-248 5/15/2017 6/16/2017
New Enabling Technologies Integration and Validation of Emerging Technologies to Accelerate Cancer Research (R33) RFA-CA-17-023 4/10/2017 5/11/2017
Cancer Immunotherapy Translational Science Network Canine Immunotherapy Trials and Correlative Studies (U01) RFA-CA-17-001 2/7/2017 3/8/2017
Cancer Immunotherapy Translational Science Network Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24) RFA-CA-17-002 2/7/2017 3/8/2017
Cancer Immunotherapy Translational Science Network Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01) RFA-CA-17-015 2/7/2017 3/8/2017
Cancer Immunotherapy Translational Science Network Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24) RFA-CA-17-016 2/7/2017 3/8/2017
Cancer Immunotherapy Translational Science Network Cancer Immune Monitoring and Analysis Centers (CIMACs) (U24) RFA-CA-17-005 2/17/2017 3/18/2017
Cancer Immunotherapy Translational Science Network Cancer Immunologic Data Common (CIDC) (U24) RFA-CA-17-006 2/17/2017 3/18/2017
Therapeutic Target Identification to Overcome Resistance Mechanisms of Cancer Drug Resistance and Sensitivity (U54) RFA-CA-17-009 2/3/2017 3/4/2017
National Cancer Data Ecosystem PDX Development and Trial Centers (PDTCs) (U54) RFA-CA-17-003 2/3/2017 3/4/2017
National Cancer Data Ecosystem PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24) RFA-CA-17-004 2/3/2017 3/4/2017
  • Updated: August 21, 2017

Most text on the National Cancer Institute website may be reproduced or reused freely. The National Cancer Institute should be credited as the source and a link to this page included, e.g., “Cancer Moonshot℠ – Funding Opportunities was originally published by the National Cancer Institute.”

Please note that blog posts that are written by individuals from outside the government may be owned by the writer, and graphics may be owned by their creator. In such cases, it is necessary to contact the writer, artists, or publisher to obtain permission for reuse.

We welcome your comments on this post. All comments must follow our comment policy.